Literature DB >> 19015737

Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome.

Bristol Sorensen1, James F Jones, Suzanne D Vernon, Mangalathu S Rajeevan.   

Abstract

Complement activation resulting in significant increases of C4a split product may be a marker of postexertional malaise in individuals with chronic fatigue syndrome (CFS). This study focused on identification of the transcriptional control that may contribute to the increased C4a in CFS subjects after exercise. We used quantitative reverse-transcription polymerase chain reaction to evaluate differential expression of genes in the classical and lectin pathways in peripheral blood mononuclear cells (PBMCs). Calibrated expression values were normalized to the internal reference gene peptidylpropyl isomerase B (PPIB), the external reference gene ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit (rbcL), or the geometric mean (GM) of the genes ribosomal protein, large, P0 (RPLP0) and phosphoglycerate kinase 1 (PGK1). All nine genes tested, except mannose-binding lectin 2 (MBL2), were expressed in PBMCs. At 1 hour postexercise, C4, mannan-binding lectin serine protease 2 (MASP2) and ficolin 1 (FCN1) transcripts were detected at higher levels (> or = 2-fold) in at least 50% (4 of 8) of CFS subjects and were detected in 88% (7 of 8) CFS subjects when subjects with overexpression of either C4 or MASP2 were combined. Only an increase in the MASP2 transcript was statistically significant (PPIB, P = 0.001; GM, P = 0.047; rbcL, P = 0.045). This result may be due to the significant but transient downregulation of MASP2 in control subjects (PPIB, P = 0.023; rbcL, P = 0.027). By 6 hours postexercise, MASP2 expression was similar in both groups. In conclusion, lectin pathway responded to exercise differentially in CFS than in control subjects. MASP2 down-regulation may act as an antiinflammatory acute-phase response in healthy subjects, whereas its elevated level may account for increased C4a and inflammation-mediated postexertional malaise in CFS subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015737      PMCID: PMC2583111          DOI: 10.2119/molmed.2008.00098

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  56 in total

1.  The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.

Authors:  Jennifer M Glass; Angela K Lyden; Frank Petzke; Phyllis Stein; Gail Whalen; Kirsten Ambrose; George Chrousos; Daniel J Clauw
Journal:  J Psychosom Res       Date:  2004-10       Impact factor: 3.006

2.  Universal reference method for real-time PCR gene expression analysis of preimplantation embryos.

Authors:  Neil Ivan Bower; Ralf Joachim Moser; Jonathan Robert Hill; Sigrid Arabella Lehnert
Journal:  Biotechniques       Date:  2007-02       Impact factor: 1.993

3.  Exercise can reverse quadriceps sensorimotor dysfunction that is associated with rheumatoid arthritis without exacerbating disease activity.

Authors:  L M Bearne; D L Scott; M V Hurley
Journal:  Rheumatology (Oxford)       Date:  2002-02       Impact factor: 7.580

4.  Complement activation after prolonged exercise.

Authors:  B Dufaux; U Order
Journal:  Clin Chim Acta       Date:  1989-01-13       Impact factor: 3.786

5.  Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus.

Authors:  F Moosig; F Damm; A Knorr-Spahr; M Ritgen; R A Zeuner; M Kneba; M Ernst; J O Schröder
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

6.  Effects of aerobic conditioning in lupus fatigue: a pilot study.

Authors:  L C Robb-Nicholson; L Daltroy; H Eaton; V Gall; E Wright; L H Hartley; P H Schur; M H Liang
Journal:  Br J Rheumatol       Date:  1989-12

7.  Exercise treatment for depression: efficacy and dose response.

Authors:  Andrea L Dunn; Madhukar H Trivedi; James B Kampert; Camillia G Clark; Heather O Chambliss
Journal:  Am J Prev Med       Date:  2005-01       Impact factor: 5.043

8.  Synthesis and regulation of complement components by human monocytes/macrophages and by acute monocytic leukemia.

Authors:  F Vincent; H de la Salle; A Bohbot; J P Bergerat; G Hauptmann; F Oberling
Journal:  DNA Cell Biol       Date:  1993-06       Impact factor: 3.311

9.  Chronic fatigue syndrome--a clinically empirical approach to its definition and study.

Authors:  William C Reeves; Dieter Wagner; Rosane Nisenbaum; James F Jones; Brian Gurbaxani; Laura Solomon; Dimitris A Papanicolaou; Elizabeth R Unger; Suzanne D Vernon; Christine Heim
Journal:  BMC Med       Date:  2005-12-15       Impact factor: 8.775

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  9 in total

1.  Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Timothy A Vanhaitsma; Kathleen C Light
Journal:  Psychosom Med       Date:  2011-12-30       Impact factor: 4.312

2.  Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.

Authors:  Alicia K Smith; Hong Fang; Toni Whistler; Elizabeth R Unger; Mangalathu S Rajeevan
Journal:  Neuropsychobiology       Date:  2011-09-09       Impact factor: 2.328

3.  Effect of different resistance-training regimens on the WNT-signaling pathway.

Authors:  Marcelo Larciprete Leal; Leonardo Lamas; Marcelo Saldanha Aoki; Carlos Ugrinowitsch; Marcela Sorelli Carneiro Ramos; Valmor Tricoli; Anselmo Sigari Moriscot
Journal:  Eur J Appl Physiol       Date:  2011-03-02       Impact factor: 3.078

4.  Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects.

Authors:  Alan R Light; Andrea T White; Ronald W Hughen; Kathleen C Light
Journal:  J Pain       Date:  2009-07-31       Impact factor: 5.820

5.  Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association.

Authors:  Virginia R Falkenberg; Brian M Gurbaxani; Elizabeth R Unger; Mangalathu S Rajeevan
Journal:  Neuromolecular Med       Date:  2010-10-13       Impact factor: 3.843

6.  Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Authors:  Ekua W Brenu; Mieke L van Driel; Don R Staines; Kevin J Ashton; Sandra B Ramos; James Keane; Nancy G Klimas; Sonya M Marshall-Gradisnik
Journal:  J Transl Med       Date:  2011-05-28       Impact factor: 5.531

7.  Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome.

Authors:  Kathleen C Light; Andrea T White; Scott Tadler; Eli Iacob; Alan R Light
Journal:  Pain Res Treat       Date:  2011-09-29

8.  Identification of Phosphoglycerate Kinase 1 (PGK1) as a reference gene for quantitative gene expression measurements in human blood RNA.

Authors:  Virginia R Falkenberg; Toni Whistler; Janna' R Murray; Elizabeth R Unger; Mangalathu S Rajeevan
Journal:  BMC Res Notes       Date:  2011-09-06

9.  Gene Expression in Response to Exercise in Patients with Chronic Fatigue Syndrome: A Pilot Study.

Authors:  Andrew Keech; Ute Vollmer-Conna; Benjamin K Barry; Andrew R Lloyd
Journal:  Front Physiol       Date:  2016-09-22       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.